Role of MMP-9 in epithelial-mesenchymal transition of thyroid cancer, World Journal of Surgical Oncology
Role of MMP-9 in epithelial-mesenchymal transition of thyroid cancer, World Journal of Surgical Oncology
Background The purpose of this study is to explore the role and mechanism of MMP-9 in the EMT process of thyroid cancer (TC), so as to provide a basis for clinical exploration of invasion and metastasis process of TC, looking for biological markers of tumor metastasis and molecular intervention therapy. Methods Western blot and RT-PCR were employed to detect the expression of MMP-9 in human normal thyroid cell line HT-ori3 and human TC cell lines IHH-4 (PTC), FTC-133, and 8505C. Expression levels of EMT-related markers: epithelial cell marker E-cadherin and stromal cell marker Vimentin in TGF-1-induced TC cell lines were detected by Western blot and RT-PCR, respectively. The effects of MMP-9 downregulation on cell invasion and metastasis were investigated by wound-healing assay and cell invasion experiment. Results The protein and mRNA expression levels of MMP-9 in TC cell lines were increased compared with the human normal thyroid cell line HT-ori3. When TGF-β1 was added, the expression of EMT and Vimentin increased while the expression of E-cadherin decreased. Compared with the control group, the TC cells stably transfected with MMP-9 shRNA showed inhibited EMT, decreased Vimentin expression, and increased E-cadherin expression. The induction of TGF-β1 did not promote the occurrence of EMT in TC cells which were stably transformed with MMP-9 shRNA. The addition of TGF-β1 to TC cells increased the ability of the cells to migrate and invade. Compared with the control group, the migration and invasion ability of TC cells stably transfected with MMP-9 shRNA was significantly reduced, and the induction of TGF-β1 could not restore the migration and invasion ability of cells without MMP-9. Conclusions In conclusion, we found that MMP-9 can be used as a biomarker for TC, which can promote the EMT process of TGF-β1 induced TC, and thus affecting the cell migration and invasion ability.
Frontiers Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology
Predictive significance of serum MMP-9 in papillary thyroid carcinoma
Diagnostic and prognostic values of MMP-9 expression in ovarian cancer: A study based on bioinformatics analysis and meta-analysis - Changyu Liu, Ying Shen, Qiyan Tan, 2023
Endocrines, Free Full-Text
Novel miR-5088-5p promotes malignancy of breast cancer by inhibiting DBC2: Molecular Therapy - Nucleic Acids
Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities - Huang - 2022 - MedComm - Wiley Online Library
Update on current diagnosis and management of anaplastic thyroid carcinoma
Long noncoding RNAs: emerging players in thyroid cancer pathogenesis in: Endocrine-Related Cancer Volume 25 Issue 2 (2018)
Role of MMP-9 in epithelial-mesenchymal transition of thyroid cancer, World Journal of Surgical Oncology
TPM3 mediates epithelial-mesenchymal transition in esophageal cancer via MMP2/MMP9 - Chen - Annals of Translational Medicine
Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies - ScienceDirect
New insight in urological cancer therapy: From epithelial-mesenchymal transition (EMT) to application of nano-biomaterials - ScienceDirect
E2F3 promotes liver cancer progression under the regulation of circ-PRKAR1B: Molecular Therapy - Nucleic Acids
LINC01816 promotes the migration, invasion and epithelial‑mesenchymal transition of thyroid carcinoma cells by sponging miR‑34c‑5p and regulating CRABP2 expression levels
Clinical significance of matrix metalloproteinase-9 expression in papillary thyroid carcinoma: a meta-analysis, World Journal of Surgical Oncology